Clinical Trial Update: Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 study of Zodasiran in adolescents with Homozygous Familial Hypercholesterolemia is not yet recruiting, according to sponsor Arrowhead Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Zodasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Homozygous Familial Hypercholesterolemia | Phase 3 | Status: NOT_YET_RECRUITING